Oncomine data-mining analysis revealed that upregulation of FASN was presented in 9 of 20 cancer types, especially in ovarian cancer, bladder cancer, colorectal cancer, and prostate cancer (Supplementary Figures S1A,B). This evidence concerns the gene FASN and prostate carcinoma.